Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia: BioCovid Study

NCT04485364 is registered in ClinicalTrials.gov with Fondation Hôpital Saint-Joseph as lead sponsor.

NCT NCT04485364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04485364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia: BioCovid Study
Lead sponsor
Fondation Hôpital Saint-Joseph
Phase
Observational
Overall status
Completed
Start date
April 14, 2020
Completion date
June 6, 2022
Enrollment
97 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, covid19